Calcium Chloride for Prevention of Uterine Atony During Cesarean

Status Completed

Clinical Trial Summary

In this pilot study, investigators will administer calcium chloride or placebo to pregnant women undergoing Cesarean delivery who have been identified as high risk for hemorrhage due to poor uterine muscle contraction, or atony. They will assess whether a single dose of calcium given immediately after the delivery of the fetus decreases the incidence of uterine atony and bleeding for the mother. The pharmacokinetics of calcium chloride in pregnant women will also be established. Data from this pilot study of 40 patients will be used to determine sample size and appropriateness of a larger randomized clinical trial.

Clinical Trial Description

Poor contraction of the uterus, also known as uterine atony, is the leading cause of severe blood loss during Cesarean section, both in the US and worldwide. Exogenous calcium has been shown to increase uterine muscle contraction in in vitro and in animal studies. Calcium is also an essential factor in normal blood clotting. Anesthesiologists commonly administer intravenous calcium chloride during Cesarean as well as other types of surgery, but formal randomized studies to determine efficacy in improving uterine tone have not been performed. In this pilot, randomized controlled study, the anesthesiologist will administer a one-time dose of intravenous calcium chloride 1gram versus placebo at the time of fetal delivery to women identified as having high risk of hemorrhage during Cesarean delivery. Primary outcome assessed will be a composite measure of uterine atony. Data from the pilot study will be used to perform power and sample size calculations for a larger study. Secondary outcomes assessed will include total blood loss, subjective assessment of uterine tone by the blinded obstetrician performing surgery, safety, side effects, and pharmacokinetic profile of calcium chloride in pregnant women. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03867383
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	March 15, 2019
Completion date	August 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04377984` - Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
Recruiting	`NCT03248817` - Phenylephrine Infusion in Cesarean Delivery	Phase 4
Completed	`NCT05037383` - Motion and Viewing Analysis of Surgeons During Minimally Invasive Gynecological Interventions	N/A
Completed	`NCT05933993` - Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
Recruiting	`NCT05021315` - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection	Phase 3
Terminated	`NCT03246919` - Ideal Time of Oxytocin Infusion During Cesarean Section	Phase 4
Recruiting	`NCT06247852` - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Not yet recruiting	`NCT06017076` - Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery.	N/A
Completed	`NCT05005871` - Comparison of Quadratus Lumborum Intramuscular and Transmuscular in Postoperative Pain	N/A
Recruiting	`NCT04518176` - Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins	N/A
Not yet recruiting	`NCT04505644` - Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section	N/A
Not yet recruiting	`NCT03985618` - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity	N/A
Completed	`NCT04046510` - Comparaison of 3 Protocols of Ocytocin Administration in C Section	N/A
Completed	`NCT03302039` - Three Protocols for Phenylephrine Administration in Cesarean Delivery	Phase 4
Completed	`NCT03318536` - Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section
Recruiting	`NCT03682510` - B-Lynch Transverse Compression Suture Versus a Sandwich Technique (N&H Technique) for Complete Placenta Previa	N/A
Recruiting	`NCT03651076` - Traxi Panniculus Retractor for Cesarean Delivery	N/A
Not yet recruiting	`NCT06060327` - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section	N/A
Completed	`NCT03701048` - Rectus Musle Reapproximation During Cesarean Section	N/A
Completed	`NCT04897841` - Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain Control	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.